The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival
暂无分享,去创建一个
G. Woods | R. Chung | Gregory M Woods | H. McGee | Heather M McGee | Bill Bennett | Roger S Chung | B. Bennett
[1] D. Lawrence,et al. Extracellular metallothionein effects on lymphocyte activities. , 1990, Molecular immunology.
[2] C. Tohyama,et al. Metallothionein deficiency promotes mouse skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. , 1998, Cancer research.
[3] C. Tohyama,et al. Cutaneous metallothionein induction by ultraviolet B irradiation in interleukin-6 null mice. , 2000, The Journal of investigative dermatology.
[4] X. Montalban,et al. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis , 2001, Journal of Neuroimmunology.
[5] S. Himeno,et al. Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[6] R. Chung,et al. A role for extracellular metallothioneins in CNS injury and repair , 2004, Neuroscience.
[7] K. Sugita,et al. Immunohistochemical Analysis of Metallothionein Expression in Malignant Melanoma in Japanese Patients , 2001, The American Journal of dermatopathology.
[8] J. Klein,et al. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. , 2001, The Journal of pharmacology and experimental therapeutics.
[9] B. Fowler,et al. Metallothionein expression in invasive and in situ breast carcinomas. , 2005, Cancer detection and prevention.
[10] T. Virolle,et al. NF‐κB/Egr‐1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death , 2005, The EMBO journal.
[11] V. Berezin,et al. Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low‐density lipoprotein receptor family , 2007, Journal of neurochemistry.
[12] J. Hidalgo,et al. Retracted: Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis , 2003, Journal of neuroscience research.
[13] H. Zhang,et al. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. , 2000, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[14] Sean Jiang,et al. Interaction of metallothionein with tumor suppressor p53 protein , 2006, FEBS letters.
[15] I. Hashimoto,et al. Possible role of cutaneous metallothionein in protection against photo-oxidative stress--epidermal localization and scavenging activity for superoxide and hydroxyl radicals. , 1992, Photodermatology, photoimmunology & photomedicine.
[16] G. Stark,et al. α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences , 1985, Nature.
[17] V. Berezin,et al. Peptides modeled after the alpha-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons. , 2009, European journal of cell biology.
[18] S Thameem Dheen,et al. Metallothionein 2A expression is associated with cell proliferation in breast cancer. , 2002, Carcinogenesis.
[19] Metallothionein expression and zinc levels in invasive ductal breast carcinoma. , 1999, Oncology reports.
[20] R. Palmiter,et al. Molecular biology of metallothionein gene expression. , 1987, Experientia. Supplementum.
[21] W. Böcker,et al. Immunohistochemically demonstrated metallothionein expression in malignant melanoma , 1993, Histopathology.
[22] J. Koropatnick,et al. Metallothionein Mediates the Level and Activity of Nuclear Factor ΚB in Murine Fibroblasts , 2004, Journal of Pharmacology and Experimental Therapeutics.
[23] P. Tan,et al. Metallothionein 1F mRNA Expression Correlates with Histological Grade in Breast Carcinoma , 2001, Breast Cancer Research and Treatment.
[24] R. Tyrrell,et al. Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts. , 2004, The Journal of investigative dermatology.
[25] B. Bay,et al. Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells. , 2009, Cancer letters.
[26] A. Ouellette. Metallothionein mRNA expression in fetal mouse organs. , 1982, Developmental biology.
[27] R. Palmiter,et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. , 1994, Biochemistry.
[28] Y. Aragane,et al. UVB Light Induces Nuclear Factor κB (NFκB) Activity Independently from Chromosomal DNA Damage in Cell-Free Cytosolic Extracts , 1994 .
[29] G. Weinlich,et al. Metallothionein‐overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients , 2003, The British journal of dermatology.
[30] Jie Liu,et al. Metallothionein-I/II Double Knockout Mice Are Hypersensitive to Lead-Induced Kidney Carcinogenesis , 2004, Cancer Research.
[31] J. Youn,et al. Immunomodulatory activities of extracellular metallothionein. II. Effects on macrophage functions. , 1995, Journal of toxicology and environmental health.
[32] S. Beissert,et al. Phenotypic and Functional Characterization of Ultraviolet Radiation-Induced Regulatory T Cells1 , 2008, The Journal of Immunology.
[33] A. Ponsonby,et al. UVR, Vitamin D and Three Autoimmune Diseases—Multiple Sclerosis, Type 1 Diabetes, Rheumatoid Arthritis , 2005, Photochemistry and photobiology.
[34] M. Ichihashi,et al. A Zn(II)–glycine complex suppresses UVB‐induced melanin production by stimulating metallothionein expression , 2008, International journal of cosmetic science.
[35] R. Palmiter,et al. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Gange,et al. Protective effects of cadmium chloride against UVB injury in mouse skin and in cultured human cells: a possible role of cadmium-induced metallothionein. , 1991, Photodermatology, photoimmunology & photomedicine.
[37] T. Sugiura,et al. B cell stimulating activity of metallothionein in vitro. , 2000, International journal of immunopharmacology.
[38] H. Chan,et al. The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells. , 1997, The Journal of pharmacology and experimental therapeutics.
[39] H. Goulding,et al. Metallothionein expression in human breast cancer. , 1995, British Journal of Cancer.
[40] A. Naganuma,et al. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. , 1993, Cancer research.
[41] J. Hidalgo,et al. Metallothionein Treatment Reduces Proinflammatory Cytokines IL-6 and TNF-α and Apoptotic Cell Death during Experimental Autoimmune Encephalomyelitis (EAE) , 2001, Experimental Neurology.
[42] I. Bremner. Nutritional and physiologic significance of metallothionein. , 1991, Methods in enzymology.
[43] V. Adhami,et al. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. , 2003, Neoplasia.
[44] C. Tohyama,et al. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice. , 2003, Carcinogenesis.
[45] Terence Dwyer,et al. Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.
[46] Y. Miyachi,et al. Suppression of melanogenesis by induction of endogenous intracellular metallothionein in human melanocytes , 2004, Experimental dermatology.
[47] Y. Aragane,et al. Ultraviolet Radiation-Induced Regulatory T Cells Not Only Inhibit the Induction but Can Suppress the Effector Phase of Contact Hypersensitivity1 , 2004, The Journal of Immunology.
[48] S. Dunlop,et al. Redefining the Role of Metallothionein within the Injured Brain , 2008, Journal of Biological Chemistry.
[49] J. Inoue,et al. Regulatory role of metallothionein in NF‐κB activation , 1999 .
[50] S. Garrett,et al. Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. , 2001, The American journal of pathology.
[51] J. Youn,et al. Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[52] H. Gali-Muhtasib,et al. Protective effect of vitamin E on ultraviolet B light–induced damage in keratinocytes , 2002, Molecular carcinogenesis.
[53] M. Lynes,et al. Augmented humoral immune function in metallothionein-null mice. , 2000, Toxicology and applied pharmacology.
[54] J. Lee,et al. The photoprotective effect of 1,25-dihydroxyvitamin D3 on ultraviolet light B-induced damage in keratinocyte and its mechanism of action. , 1997, Journal of dermatological science.
[55] N. Miura,et al. Novel Function of Metallothionein in Photoprotection: Metallothionein-Null Mouse Exhibits Reduced Tolerance Against Ultraviolet B Injury in the Skin , 1998 .
[56] T. Kimura,et al. Function of Metallothionein in Gene Expression and Signal Transduction: Newly Found Protective Role of Metallothionein , 2008 .
[57] D. Lamm,et al. Metallothionein isoform 3 as a potential biomarker for human bladder cancer. , 2000, Environmental health perspectives.
[58] P. Tan,et al. Over‐expression of metallothionein predicts chemoresistance in breast cancer , 2009, The Journal of pathology.
[59] B. Bay,et al. Up-regulation of metallothionein isoforms in keloid keratinocytes. , 2006, International journal of molecular medicine.
[60] C. Scaletta,et al. Evidence that ferritin is UV inducible in human skin: part of a putative defense mechanism. , 1998, The Journal of investigative dermatology.
[61] R. Tyrrell,et al. ACTIVATION OF NF‐KB IN HUMAN SKIN FIBROBLASTS BY THE OXIDATIVE STRESS GENERATED BY UVA RADIATION , 1995, Photochemistry and photobiology.
[62] G. Weinlich,et al. Metallothionein – overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients , 2006, British Journal of Cancer.
[63] S. Tseng,et al. Keratin classes: molecular markers for different types of epithelial differentiation. , 1983, The Journal of investigative dermatology.
[64] M. Chatterjee,et al. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression. , 2007, Life sciences.
[65] N. Nishimura,et al. Lack of metallothionein‐I and ‐II exacerbates the immunosuppressive effect of ultraviolet B radiation and cis‐urocanic acid in mice , 2000, Immunology.
[66] J. Youn,et al. Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation. , 1996, Toxicology.
[67] H. Hashimoto,et al. Immunohistochemical expression of metallothionein in human bladder cancer: correlation with histopathological parameters and patient survival. , 2002, The Journal of urology.
[68] M. Vašák. Advances in metallothionein structure and functions. , 2005, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[69] T. Yoshida,et al. Metallothionein synthesis induced by interferon alpha/beta in mice of various zinc status. , 1996, The Tohoku journal of experimental medicine.
[70] D. Whiteman,et al. Isoflavonoid photoprotection in mouse and human skin is dependent on metallothionein. , 2006, The Journal of investigative dermatology.
[71] Manuela Gariboldi,et al. Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma , 2008, Laboratory Investigation.
[72] L. Stitt,et al. Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder. , 2006, Urology.
[73] S. Garrett,et al. Post-transcriptional regulation of metallothionein isoform 1 and 2 expression in the human breast and the MCF-10A cell line. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[74] J. Lazo,et al. Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice. , 1999, Carcinogenesis.
[75] H. V. Van Poppel,et al. Metallothioneins in Human Kidneys and Associated Tumors , 1999, Nephron.
[76] T. Schwarz. Regulatory T Cells Induced by Ultraviolet Radiation , 2005, International Archives of Allergy and Immunology.
[77] G. Guillemin,et al. Metallothionein Treatment Attenuates Microglial Activation and Expression of Neurotoxic Quinolinic Acid Following Traumatic Brain Injury , 2009, Neurotoxicity Research.
[78] K. Zedeler,et al. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. , 1994, Pathology, research and practice.
[79] H. Hojo,et al. Tissue specific induction of metallothionein synthesis by tumor necrosis factor-alpha. , 1992, Research communications in chemical pathology and pharmacology.
[80] S. Dunlop,et al. Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways , 2010, Experimental Neurology.
[81] Jung Mogg Kim,et al. Functions of metallothionein generating interleukin-10-producing regulatory CD4+ T cells potentiate suppression of collagen-induced arthritis. , 2007, Journal of microbiology and biotechnology.
[82] P. Epstein,et al. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.
[83] T. Dwyer,et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.
[84] K. Zedeler,et al. The prognostic significance of immunohistochemically detectable metallothionein in primary breast carcinomas , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[85] G. Halliday,et al. Ultraviolet B but Not A Radiation Activates Suppressor B Cells in Draining Lymph Nodes , 2005, Photochemistry and photobiology.
[86] M. Kanda,et al. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. , 2009, International journal of oncology.
[87] K. Horgan,et al. Metallothionein expression in duct carcinoma in situ of the breast. , 1995, Human pathology.
[88] R. Matkowski,et al. Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance. , 2005, Histology and histopathology.
[89] G. Cavaletti,et al. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. , 2004, Journal of biological regulators and homeostatic agents.
[90] S. Oikawa,et al. Role of ultraviolet A-induced oxidative DNA damage in apoptosis via loss of mitochondrial membrane potential and caspase-3 activation. , 1998, Biochemical and biophysical research communications.
[91] C. Tohyama,et al. Localization of metallothionein in hair follicles of normal skin and the basal cell layer of hyperplastic epidermis: possible association with cell proliferation. , 1991, The Journal of investigative dermatology.
[92] A. Michalska,et al. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[93] X.-Y. Lu,et al. Metallothionein‐null mice exhibit reduced tolerance to ultraviolet B injury in vivo , 2004, Clinical and experimental dermatology.
[94] C. E. Hildebrand,et al. Human metallothionein genes: structure of the functional locus at 16q13. , 1990, Genomics.
[95] J. Jester,et al. A role for NF-κB–dependent gene transactivation in sunburn , 2000 .
[96] H. Takano,et al. Role of metallothionein in lung inflammation induced by ozone exposure in mice. , 2008, Free radical biology & medicine.
[97] J. Alam,et al. Metallothionein protects retinal pigment epithelial cells against apoptosis and oxidative stress. , 2002, Experimental eye research.
[98] B. Epe,et al. Wavelength dependence of oxidative DNA damage induced by UV and visible light. , 1997, Carcinogenesis.
[99] A. Ponsonby,et al. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. , 2003, Environmental health perspectives.
[100] C. Séguin,et al. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. , 1998, DNA and cell biology.
[101] S. De,et al. High levels of metallothionein messenger RNAs in male germ cells of the adult mouse. , 1991, Molecular endocrinology.
[102] M. Karin,et al. Glucocorticoid hormone receptor mediated induction of metallothionein synthesis in HeLa cells , 1980, Journal of cellular physiology.
[103] G. Halliday,et al. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. , 2005, The Journal of investigative dermatology.
[104] L. Beazley,et al. Metallothionein-IIA promotes neurite growth via the megalin receptor , 2007, Experimental Brain Research.
[105] J. Vickers,et al. Protective Role of Metallothioneins in the Injured Mammalian Brain , 2004, Reviews in the neurosciences.
[106] D. Wynford‐Thomas,et al. IN VIVO PHOTOINDUCTION OF METALLOTHIONEIN IN HUMAN SKIN BY ULTRAVIOLET IRRADIATION , 1996, The Journal of pathology.
[107] S. Katiyar,et al. Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. , 2006, Free radical biology & medicine.
[108] D. Lawrence,et al. Manipulations of metallothionein gene dose accelerate the response to Listeria monocytogenes. , 2009, Chemico-biological interactions.
[109] S. Fukushima,et al. Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine , 2003, Cancer science.
[110] S. Dey,et al. Metallothionein gene expression and metal regulation during preimplantation mouse embryo development (MT mRNA during early development). , 1991, Developmental biology.
[111] A. Farrag,et al. Mean Nuclear Area and Metallothionein Expression in Ductal Breast Tumors: Correlation With Estrogen Receptor Status , 2008, Applied immunohistochemistry & molecular morphology : AIMM.
[112] W. Schaffner,et al. The transcription factor MTF‐1 is essential for basal and heavy metal‐induced metallothionein gene expression. , 1994, The EMBO journal.
[113] R. Cousins,et al. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[114] G. Weinlich,et al. Comparison of metallothionein‐overexpression with sentinel lymph node biopsy as prognostic factors in melanoma , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.
[115] G. Murphy,et al. The molecular determinants of sunburn cell formation , 2001, Experimental dermatology.
[116] Hyung Gyun Kim,et al. Metallothionein-III provides neuronal protection through activation of nuclear factor-kappaB via the TrkA/phosphatidylinositol-3 kinase/Akt signaling pathway. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[117] Paul J Thornalley,et al. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. , 1985, Biochimica et biophysica acta.
[118] V. Berezin,et al. The role of metallothionein II in neuronal differentiation and survival , 2003, Brain Research.
[119] D. Whiteman,et al. Induction of metallothionein in human skin by routine exposure to sunlight: evidence for a systemic response and enhanced induction at certain body sites. , 2003, The Journal of investigative dermatology.
[120] R. Palmiter,et al. Regulation, linkage, and sequence of mouse metallothionein I and II genes , 1984, Molecular and cellular biology.
[121] B. Pitt,et al. Antioxidant and antiapoptotic function of metallothioneins in HL-60 cells challenged with copper nitrilotriacetate. , 2000, Chemical research in toxicology.
[122] J. Kumazawa,et al. Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract. , 1994, The Journal of urology.
[123] A. Naba,et al. Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity. , 2009, International journal of oncology.
[124] A. Abdel-Mageed,et al. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. , 1997, Cancer gene therapy.
[125] K. Squibb,et al. Induction of metallothionein and heme oxygenase in rats after inhalation of endotoxin. , 1999, Journal of toxicology and environmental health. Part A.
[126] J. Hidalgo,et al. Retracted: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis , 2000, Glia.
[127] R. Palmiter,et al. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[128] Catherine Méplan,et al. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells , 2000, Oncogene.
[129] R. Alcalde,et al. Zinc accumulation and metallothionein gene expression in the proliferating epidermis during wound healing in mouse skin , 1999, Histochemistry and Cell Biology.
[130] Z. Ryoo,et al. Metallothionein suppresses collagen‐induced arthritis via induction of TGF‐β and down‐regulation of proinflammatory mediators , 2002, Clinical and experimental immunology.
[131] B. Vallee,et al. Cell cycle regulation of metallothionein in human colonic cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[132] R. Tyrrell,et al. UVA radiation-induced oxidative damage to lipids and proteins in vitro and in human skin fibroblasts is dependent on iron and singlet oxygen. , 1995, Free radical biology & medicine.
[133] H. Degreef,et al. Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB , 2004, Archives of Dermatological Research.
[134] T. Nakajima,et al. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. , 1996, Oncology.
[135] M. Fear,et al. Exogenous metallothionein‐IIA promotes accelerated healing after a burn wound , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[136] D. Knecht,et al. Metallothionein mediates leukocyte chemotaxis , 2005, BMC Immunology.
[137] Xiuyun Yin,et al. The Physiological Roles of Extracellular Metallothionein , 2006, Experimental biology and medicine.
[138] M. Lynes,et al. In vivo manipulation of endogenous metallothionein with a monoclonal antibody enhances a T-dependent humoral immune response. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[139] J. Youn,et al. Immunomodulatory activities of extracellular metallothionein. I. Metallothionein effects on antibody production. , 1993, Toxicology.
[140] M. Kanekiyo,et al. Metallothionein modulates lipopolysaccharide-stimulated tumour necrosis factor expression in mouse peritoneal macrophages , 2002 .
[141] Yongping Cui,et al. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. , 2003, Biochemical and biophysical research communications.
[142] S. Katiyar,et al. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. , 2007, Free radical biology & medicine.
[143] R. Palmiter,et al. MT-III, a brain-specific member of the metallothionein gene family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[144] J. Hidalgo,et al. New insight into the molecular pathways of metallothionein‐mediated neuroprotection and regeneration , 2007, Journal of neurochemistry.
[145] J. Vickers,et al. Metallothionein-IIA Promotes Initial Neurite Elongation and Postinjury Reactive Neurite Growth and Facilitates Healing after Focal Cortical Brain Injury , 2003, The Journal of Neuroscience.